Sherzod Abdullaev

41 та иш

Tashkent Pediatric Medical Institute Department of Internal Medicine Tashkent Uzbekistan

1. SAT-334 DISPARITIES IN TRANSPLANTATION ACCESS ACROSS DIFFERENT COUNTRIES: AN ISN FELLOWS COLLABORATIVE STUDY

   Mahmoud E. Elrggal, Sibel Gökçay Bek, Elliot Koranteng Tannor +8

   МақолаOrgan Donation and TransplantationKidney International Reports20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.002348

2. P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS

   Sherzod Abdullaev, Ranokhon Igamberdieva

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.002654

3. P0317EARLY MARKERS OF RENAL INJURY AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME

   Sherzod Abdullaev

   МақолаHealthcare Systems and Public HealthNephrology Dialysis Transplantation20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.002655

4. Epidemiological, clinical and morphological aspects of kidney damage in COVID-19

   Batir Daminov, Sherzod Abdullaev, Olimkhon Sharapov +1

   МақолаCOVID-19 Clinical Research StudiesJournal of Renal Injury Prevention20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.001967

5. MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.002955

6. POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION

   Ranokhon Igamberdieva, Sherzod Abdullaev, Olimkhon Sharapov

   МақолаNeurological Disorders and TreatmentsKidney International Reports20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.004689

7. MO528INFLUENCE OF CARDIOVASCULAR DISEASES ON SURVIVAL RATES IN DIALYSIS PATIENTS IN A COHORT OF THE UZBEK POPULATION

   Olimkhon Sharapov, Sherzod Abdullaev

   МақолаChronic Disease Management StrategiesNephrology Dialysis Transplantation20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.005893

8. MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.006221

9. MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF

   Ranokhon Igamberdieva, Sherzod Abdullaev

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.002165

10. POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesKidney International Reports20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.002924

11. POS-592 COMPARATIVE ANALYSIS OF THE CAUSES OF DEATH IN DIALYSIS PATIENTS WITH AND WITHOUT CARDIOVASCULAR DISEASES

    Olimkhon Sharapov, Botir Daminov, Sherzod Abdullaev

    МақолаBlood Pressure and Hypertension StudiesKidney International Reports20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.002955

12. POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаAtrial Fibrillation Management and OutcomesKidney International Reports20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.002970

13. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.004913

14. MO634: Effects of Dapagliflozin in Patients with Heart Failure

    Sherzod Abdullaev, Olimkhon Sharapov

    МақолаDiabetes Treatment and ManagementNephrology Dialysis Transplantation20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.004922

15. MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.004975

16. MO143: Dynamics of Renal Function during Anticoagulant Therapy in Stage 4 CKD and AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.004978

17. Oral anticoagulation in end-stage CKD and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesInternational Journal of Health Sciences20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.007035

18. Awareness of chronic kidney disease and its risk factors in the former Soviet Union countries

    Alimzhan Muxunov, N. Bulanov, Sultan Makhmetov +9

    МақолаBlood Pressure and Hypertension StudiesElectronic Journal of General Medicine20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.002007

19. #3055 ASSOCIATION OF MORTALITY WITH INTRADIALYTIC EXERCISE IN HEMODIALYSIS PATIENTS

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаDialysis and Renal Disease ManagementNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.002567

20. #3896 SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.003120

21. #3440 TOCILIZUMAB INDUCTION THERAPY IN KIDNEY TRANSPLANTATION

    Sherzod Abdullaev, Olimkhon Sharapov

    МақолаRenal Transplantation Outcomes and TreatmentsNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.003791

22. #4691 LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

    Olimkhon Sharapov, Sherzod Abdullaev

    МақолаGenetic and Kidney Cyst DiseasesNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.008408

23. #2765 EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD

    Sherzod Abdullaev, Olimkhon Sharapov, Ranokhon Igamberdieva

    МақолаSARS-CoV-2 and COVID-19 ResearchNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.008409

24. #3015 EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD

    Sherzod Abdullaev, Olimkhon Sharapov

    МақолаDiabetes Treatment and ManagementNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.008410

25. #3897 STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF THE HEART IN ELDERLY AND OLD PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаHealthcare Systems and Public HealthNephrology Dialysis Transplantation20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.008418